Charterhouse sells Italian pharma company to CVC
The deal is understood to be in the range of €650 to €700 million and is slated to close in mid-2016.
15 March 2016•1 min read
The deal is understood to be in the range of €650 to €700 million and is slated to close in mid-2016.
